SCHEMBL260294

SCHEMBL260294

CCC(C(=O)O)c1c[nH]c2cccc([N+](=O)[O-])c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.45
TSHR P16473 1/20 0.45
BACE1 P56817 2/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
PKM P14618 1/20 0.41
GPR84 Q9NQS5 1/20 0.40
CDK2 P24941 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
CLK1 P49759 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819570 0.83 BACE1 (0.44) CYP1A2TSHRBACE1KMT2AMEN1
SCHEMBL475205 0.77 CYP1A2 (0.72) CYP1A2TSHRKMT2AMEN1ALDH1A1
SCHEMBL475201 0.77 CYP1A2 (0.72) CYP1A2TSHRKMT2AMEN1ALDH1A1
SCHEMBL260657 0.76 CYP1A2 (0.40) CYP1A2TSHRKMT2AMEN1MAPT
SCHEMBL148211 0.76 MAPT (0.68) TSHRKMT2AMEN1MAPTPKM
SCHEMBL260240 0.75 FBP1 (0.41) CYP1A2TSHRKMT2AMEN1MAPT
SCHEMBL4656906 0.74 CYP1A2 (0.52) CYP1A2TSHRKMT2AMEN1MAPT
SCHEMBL28915757 0.74 CLK1 (0.43) CYP1A2BACE1KMT2AMEN1MAPT
SCHEMBL20120119 0.73 SMN1; SMN2 (0.59) TSHRBACE1KMT2AMEN1MAPT
SCHEMBL20120121 0.73 DNA2 (0.56) TSHRBACE1GPR84CDK2CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163752-B2 Tricyclic anilide heterocyclic CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-04-24 US disclosed
US-8133891-B2 Tricyclic anilide spirolactam CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-03-13 US disclosed